Daniel specialises in advising and representing national and international clients in the life sciences sector. His focus is, among others, on all areas of pharmaceutical law, medical device law, pharmaceutical-advertising law, unfair competition law, and trademark law.

 

For more than 10 years, he has been coordinating and supervising disputes concerning competition law and trademark law for his clients and has, besides his specific focus on litigation, also longstanding experience in advising clients on regulatory and compliance matters, particularly, in the aforementioned areas of law. In context with managing litigation and advising his clients, Daniel is characterised by a strong client focus and his ability to find appropriate and efficient solutions to legal problems.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Sciences de la vie et Santé

Telehealth advertising admissible if accepted professional standards are observed

18 mai 2022
Briefing

par Dr. Daniel Tietjen

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

TAMG – the new Veterinary Medicinal Products Act

18 mai 2022
Briefing

par Dr. Daniel Tietjen

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Mandatory e-prescription rollout postponed

18 mai 2022
Briefing

par Dr. Daniel Tietjen

Cliquer ici pour en savoir plus
Interface - FoodTech

The current regulatory framework for the marketing of products containing CBD

CBD in food and cosmetics: These requirements must be achieved for biscuits, muesli, soap and co. to be approved for the European internal market.

25 avril 2022
Briefing

par Dr. Daniel Tietjen

3 de 4 Publications

Cliquer ici pour en savoir plus

Autres avocats qui pourraient vous intéresser